Nukkleus Inc. Successfully Resolves Nasdaq Delisting Threat, Achieving Compliance Across All Key Parameters
Nukkleus (NASDAQ: NUKK) has successfully resolved its delisting concerns with Nasdaq, as announced on January 16, 2025. The company received notification on January 15, 2025, confirming its compliance with two important Nasdaq listing requirements: the market value of listed securities (Rule 5450(b)(2)(A)) and the market value of publicly held shares (Rule 5450(b)(2&3)(C)).
As a result of achieving compliance, the previously scheduled Nasdaq hearing for January 21, 2025, has been canceled, and NUKK's securities will continue to be listed and traded on The Nasdaq Stock Market. The management views this development as a significant milestone that demonstrates their commitment to maintaining Nasdaq's compliance standards while pursuing sustainable growth.
Nukkleus (NASDAQ: NUKK) ha risolto con successo le sue preoccupazioni relative al delisting con Nasdaq, come annunciato il 16 gennaio 2025. L'azienda ha ricevuto notifica il 15 gennaio 2025, confermando la sua conformità a due importanti requisiti di quotazione di Nasdaq: il valore di mercato dei titoli quotati (Regola 5450(b)(2)(A)) e il valore di mercato delle azioni detenute dal pubblico (Regola 5450(b)(2&3)(C)).
Di conseguenza, l'udienza precedentemente programmata di Nasdaq per il 21 gennaio 2025 è stata cancellata e i titoli di NUKK continueranno a essere quotati e negoziati sul Nasdaq Stock Market. La direzione considera questo sviluppo come un traguardo significativo che dimostra il loro impegno a mantenere gli standard di conformità di Nasdaq mentre perseguono una crescita sostenibile.
Nukkleus (NASDAQ: NUKK) ha resuelto con éxito su preocupaciones de deslistado con Nasdaq, según lo anunciado el 16 de enero de 2025. La compañía recibió la notificación el 15 de enero de 2025, confirmando su cumplimiento con dos importantes requisitos de cotización de Nasdaq: el valor de mercado de los valores listados (Regla 5450(b)(2)(A)) y el valor de mercado de las acciones en manos del público (Regla 5450(b)(2&3)(C)).
Como resultado de haber alcanzado el cumplimiento, se ha cancelado la audiencia programada de Nasdaq para el 21 de enero de 2025, y los valores de NUKK continuarán estando listados y negociados en el Nasdaq Stock Market. La dirección considera este desarrollo como un hito significativo que demuestra su compromiso con el mantenimiento de los estándares de cumplimiento de Nasdaq mientras persiguen un crecimiento sostenible.
Nukkleus (NASDAQ: NUKK)는 2025년 1월 16일에 발표된 바와 같이 나스닥의 상장 폐지 우려를 성공적으로 해결했습니다. 회사는 2025년 1월 15일에 나스닥 상장 요건 중 두 가지를 충족했다는 통지를 받았습니다: 상장된 증권의 시장 가치(규칙 5450(b)(2)(A))와 공공 소유 주식의 시장 가치(규칙 5450(b)(2&3)(C)).
컴플라이언스를 달성한 결과, 2025년 1월 21일로 예정되었던 나스닥 청문회는 취소되었으며, NUKK의 증권은 계속해서 나스닥 주식 시장에서 상장 및 거래될 것입니다. 경영진은 이러한 발전을 나스닥의 컴플라이언스 기준을 유지하고 지속 가능한 성장을 추구하는 데 대한 그들의 약속을 보여주는 중요한 이정표로 보고 있습니다.
Nukkleus (NASDAQ: NUKK) a résolu avec succès ses inquiétudes concernant le délisting avec Nasdaq, comme annoncé le 16 janvier 2025. La société a reçu une notification le 15 janvier 2025, confirmant sa conformité avec deux exigences importantes de cotation de Nasdaq : la valeur de marché des titres cotés (Règle 5450(b)(2)(A)) et la valeur de marché des actions détenues par le public (Règle 5450(b)(2&3)(C)).
En raison de cette conformité atteinte, l'audience du Nasdaq précédemment prévue pour le 21 janvier 2025 a été annulée, et les titres de NUKK continueront d'être listés et négociés sur le Nasdaq Stock Market. La direction considère ce développement comme une étape importante qui démontre leur engagement à maintenir les normes de conformité de Nasdaq tout en poursuivant une croissance durable.
Nukkleus (NASDAQ: NUKK) hat erfolgreich seine Bedenken bezüglich der Delistung mit Nasdaq gelöst, wie am 16. Januar 2025 angekündigt. Das Unternehmen erhielt am 15. Januar 2025 eine Benachrichtigung, die seine Konformität mit zwei wichtigen Listing-Anforderungen von Nasdaq bestätigt: dem Marktwert der gelisteten Wertpapiere (Regel 5450(b)(2)(A)) und dem Marktwert der im Umlauf befindlichen Aktien (Regel 5450(b)(2&3)(C)).
Infolge der Erreichung der Konformität wurde die zuvor für den 21. Januar 2025 angesetzte Nasdaq-Anhörung abgesagt, und die Wertpapiere von NUKK werden weiterhin an der Nasdaq-Börse gelistet und gehandelt. Die Geschäftsführung betrachtet diese Entwicklung als einen bedeutenden Meilenstein, der ihr Engagement für die Einhaltung der Nasdaq-Standards unter Beweis stellt, während sie nachhaltiges Wachstum anstreben.
- Successfully regained compliance with Nasdaq listing requirements
- Avoided potential delisting from Nasdaq
- Maintains access to public markets and trading status
- None.
Insights
The successful resolution of Nasdaq's delisting concerns represents a important regulatory milestone for Nukkleus. Meeting both the market value of listed securities (MVLS) and market value of publicly held shares (MVPHS) requirements demonstrates a significant improvement in the company's market position. For context, the MVLS requirement typically demands a minimum of
The cancellation of the scheduled hearing is particularly noteworthy as it indicates Nasdaq's satisfaction with Nukkleus's compliance efforts without requiring additional scrutiny or remediation plans. This development removes a substantial overhang that typically depresses stock valuations and restricts institutional investment interest. The resolution eliminates the immediate risk of forced selling that would have occurred with a delisting scenario, preserving shareholder value and market access.
For a company with a market cap of
This compliance achievement has significant structural implications for Nukkleus's market position. Retaining Nasdaq listing maintains the company's access to a deeper pool of institutional investors who often have mandate restrictions preventing investment in OTC-listed securities. The timing of this resolution, early in 2025, provides a clean slate for potential institutional accumulation without the technical overhang of delisting concerns.
The market mechanics are particularly relevant here - companies facing delisting threats typically experience reduced market maker participation and wider bid-ask spreads. With this resolution, we should expect improved trading dynamics including potentially tighter spreads and better price discovery. For retail investors, this means better execution prices and reduced trading friction. The maintenance of Nasdaq listing also preserves the company's eligibility for index inclusion, which can be a significant driver of passive investment flows.
As a result, Nasdaq has officially canceled the hearing scheduled for January 21, 2025, confirming that Nukkleus's securities will continue to be listed and traded on The Nasdaq Stock Market. This milestone highlights Nukkleus's commitment to meeting Nasdaq's rigorous compliance standards and maintaining its position as a publicly traded entity.
The management of the company believes this milestone underscores its effective resolution of all compliance matters with Nasdaq, allowing the Company to continue its pursuit of sustainable growth and deliver lasting value to its stakeholders.
About Nukkleus Inc.
Nukkleus, Inc. (NASDAQ: NUKK) is a Nasdaq company focused on innovative acquisition companies specializing in identifying, acquiring, and transforming high-potential businesses across key sectors, including defense, financial services, real estate, industrial, and technology. Focused on driving growth, innovation, and operational excellence, Nukkleus combines strategic investments with unparalleled expertise to foster collaboration and sustainable value creation. By leveraging market insights and advanced solutions, the company accelerates growth and ensures long-term success for its portfolio businesses, reshaping industries and delivering measurable returns for stakeholders.
Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms. Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Risk factors described under "Risk Factors" in Nukkleus' most recently filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law
For more information, please contact:
Yair Ohayon
CMO
l@nukk.com
View original content:https://www.prnewswire.com/news-releases/nukkleus-inc-successfully-resolves-nasdaq-delisting-threat-achieving-compliance-across-all-key-parameters-302353530.html
SOURCE Nukkleus, Inc.
FAQ
What Nasdaq compliance requirements did NUKK meet in January 2025?
When did Nukkleus (NUKK) receive confirmation of Nasdaq compliance?
What happened to NUKK's scheduled Nasdaq hearing for January 21, 2025?
Will NUKK continue trading on Nasdaq after resolving compliance issues?
